Dr. Jad N. Chémali is a researcher and educator in the field of medical research, specializing in cancer research. Originally from Lebanon, he left his country at a young age to pursue his studies in France, where he found an environment conducive to his scientific ambitions. Academic Background - Bachelor’s degree in Biochemistry and Molecular Biology from Paul Sabatier University, Toulouse III, France. - Master’s degree in Biochemistry and Biotechnology from Paul Sabatier University, Toulouse III, France. - Master 2 in Chemistry for Health, specializing in gene therapy and drug design, from Paul Sabatier University, Toulouse III, and the National Polytechnic Institute of Toulouse, France. - PhD in Chemistry-Biology-Health, focusing on the synthesis of anticancer molecules for photodynamic therapy, from Paul Sabatier University, Toulouse III, France. Career and Contributions After earning his PhD, Dr. Chémali pursued postdoctoral research at the IMRCP laboratory (CNRS, UMR 5623) in Toulouse for two years. He then returned to Lebanon to continue his cancer research, particularly focusing on drug repurposing. This approach aims to identify existing medications approved for other diseases that could be effective against cancer, thereby reducing the time and cost of developing new treatments. Research and Teaching Activities In addition to his research, Dr. Chémali is a dedicated educator at Saint Joseph University of Beirut (USJ), where he teaches at the Faculty of Medicine and the Faculty of Sciences. He is currently the director of the Cancerology and Carcinogenic Agents Laboratory at the USJ Faculty of Medicine. His research focuses on: - Developing personalized treatments for cancer patients, aiming to optimize therapies based on the individual characteristics of each patient. - Studying carcinogenic agents and their impact on the early onset of certain cancers in Lebanon. - Investigating the root causes of cancer, exploring potentially unknown phenomena that could contribute to the disease. Vision and Impact Dr. Chémali is committed to fighting cancer and is constantly seeking new and effective solutions to combat this disease. His holistic approach and willingness to explore innovative therapeutic options reflect his dedication to the field of cancer research.